Beta Carotene, CAS# 7235-40-7, is a organic compound manufactured through plant extraction, available as White or whitelike powder. Beta Carotene is widely used as nutrition supplements. It is widely accepted as safe food additive in many countries with E number E160e.
No significant side effects reported.
As Beta Carotene is widely known as safe, there is no limit on dosage of intake. However, we still recommend consumers to consult professionals before using large quantity of Beta Carotene for long period.
Special groups refer to newborns, children, pregnant and any other applicable vulnerable groups.
Beta Carotene may have some affect on pregnant or breast-feeding women. We recommend consumers to consult professionals before using Beta Carotene in food of pregnant or breast-feeding women.
Generally recognized as safe(GRAS) is a FDA designation that a specific substance or ingredient is generally considered safe by experts, and so is exempted from the usual Federal Food, Drug, and Cosmetic Act (FFDCA) food additive tolerance requirements. Beta Carotene is considered safe by FDA according to existing data and granted GRAS status.
No breaking news or public health crises reported about Beta Carotene reported up to now.
* Want to report news about this ingredient, please send email to email@example.com. Your knowledge can help us to uncover more truthes about food ingredients to customers.
1. Techniques for measuring vitamin A activity from β-carotene. [Am J Clin Nutr. 2012 Nov]
Author: Tang G.
2. The contribution of β-carotene to vitamin A supply of humans. [Mol Nutr Food Res. 2012 Feb]
Author: Weber D, Grune T.
3. In utero and lactational β-carotene supplementation attenuates D-galactose-induced hearing loss in newborn rats. [Food Chem Toxicol. 2011 Aug]
Author: Yu F, Hao S, Zhao Y, Yang H, Fan XL, Yang J.
4. Beta-carotene is an important vitamin A source for humans. [J Nutr. 2010 Dec]
Author: Grune T, Lietz G, Palou A, Ross AC, Stahl W, Tang G, Thurnham D, Yin SA, Biesalski HK.
5. Efficacy of beta-carotene topical application in melasma: an open clinical trial. [Indian J Dermatol Venereol Leprol. 2002 Nov-Dec]
Author: Kar HK.